1995
DOI: 10.1111/j.1600-0420.1995.tb00591.x
|View full text |Cite
|
Sign up to set email alerts
|

Increase of retinal vessel width in ocular hypertensives with timolol therapy

Abstract: Abstract. Purpose: The purpose of this study was to determine whether timolol drops compared to placebo drops had a significant effect on retinal vessel width in ocular hypertensives. Methods: Thirty‐seven ocular hypertensives were randomly assigned to receive placebo or 0.5% timolol drops to both eyes for 18 to 24 months in a double masked clinical trial. Measurements of ocular pressure and retinal vessel width by computerized image analysis from fundus photographs were made at about 3 month intervals for 18… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

1996
1996
2017
2017

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 12 publications
(2 citation statements)
references
References 19 publications
(34 reference statements)
0
2
0
Order By: Relevance
“…In regard to timolol, however, findings are inconsistent. Although some researchers noted increases in retinal vessel diameter (125) , most studies have found that timolol treatment causes a decrease in retinal vessel diameter (vasoconstriction) (126,127) as well as a reduction in choroidal blood flow (125) that we would expect to lead to choroidal thinning.…”
Section: Discussionmentioning
confidence: 95%
“…In regard to timolol, however, findings are inconsistent. Although some researchers noted increases in retinal vessel diameter (125) , most studies have found that timolol treatment causes a decrease in retinal vessel diameter (vasoconstriction) (126,127) as well as a reduction in choroidal blood flow (125) that we would expect to lead to choroidal thinning.…”
Section: Discussionmentioning
confidence: 95%
“…In contrast, arteriolar narrowing has been demonstrated in healthy eyes when topical beta‐blockers are used . Other investigators have found evidence of arteriolar dilation with beta‐blocker use in persons with POAG and ocular hypertensives . Latanoprost has not been found to effect retinal vessel diameter in normal or glaucomatous eyes, however has been found to induce arteriolar constriction in subjects with type 1 diabetes .…”
Section: Glaucomatous and Non‐glaucomatous Optic Neuropathiesmentioning
confidence: 97%